Stryker unveils wearable device for care team communication

Published 03/03/2025, 14:14
Stryker unveils wearable device for care team communication

PORTAGE, Mich. - Stryker Corporation (NYSE:SYK), a prominent medical technology company valued at over $147 billion, has introduced the Sync Badge, a new hands-free, wearable communication device aimed at improving teamwork and coordination among healthcare professionals. The device facilitates voice-activated interactions, allowing medical staff to remain engaged with patient care without the need for manual operation. According to InvestingPro data, Stryker maintains a "GREAT" financial health score, with robust revenue growth of 10.2% over the last twelve months.

The Sync Badge is designed to address the challenges of the healthcare setting, where efficient communication is critical, especially in light of ongoing nursing shortages. The device enables care team members to send voice commands to reach colleagues by name, role, or group, and even broadcast urgent messages or assemble rapid response teams through a wake word activation system.

Key features of the Sync Badge include a dedicated panic button for emergencies, enabling security personnel to quickly identify and respond to a staff member in distress. Additionally, a Do Not Disturb mode allows for uninterrupted focus on patient care, with options for call escalation or urgent call breakthroughs.

Integration capabilities of the Sync Badge extend to receiving alarms and notifications from connected devices and software platforms, such as electronic health records (EHR), patient monitoring systems, and scheduling tools. This integration is facilitated through Stryker’s Vocera (NYSE:VCRA) Engage middleware, which is necessary for the delivery of secondary alarms in the United States as per FDA regulations. With a gross profit margin of 64.4% and strong cash flows, Stryker demonstrates solid operational efficiency in its healthcare technology initiatives. InvestingPro analysis reveals 15+ additional insights about Stryker’s financial performance and market position.

Scott Sagehorn, vice president and general manager of Stryker’s Acute Care business, emphasized the company’s commitment to supporting healthcare staff by creating intuitive solutions like the Sync Badge to simplify their workflow and keep them connected.

Stryker is a global entity recognized for its innovative medical solutions across various specialties, including MedSurg, Neurotechnology, and Orthopaedics, impacting over 150 million patients each year. The Sync Badge is part of Stryker’s ongoing efforts to advance digital healthcare solutions that empower staff and enhance patient care.

This announcement is based on a press release statement from Stryker. For more information about the Sync Badge and Stryker’s digital healthcare solutions, visit the company’s website. While currently trading near its 52-week high, investors seeking detailed analysis can access Stryker’s comprehensive Pro Research Report, available exclusively on InvestingPro, along with in-depth financial metrics and expert insights for over 1,400 US stocks.

In other recent news, Stryker Corporation has completed the acquisition of Inari Medical (TASE:BLWV) for approximately $4.94 billion. This strategic purchase is expected to diversify Stryker’s product portfolio by incorporating Inari’s ClotTriever and FlowTriever systems, which address venous thromboembolism treatment. Citi has responded positively to this acquisition by initiating coverage with a Buy rating and setting a price target of $450 for Stryker. Analysts estimate that Inari will contribute $590 million in revenue for Stryker in 2025, despite a slight expected dilution to operating margins. Additionally, Stryker has raised $3 billion in new debt to finance the acquisition, with notes maturing between 2027 and 2035. In corporate governance news, board member Allan Golston announced his retirement, effective at the annual shareholders meeting in May 2025. Furthermore, Stryker has increased its quarterly dividend to $0.84 per share, marking a 5% rise from the previous year. These developments highlight Stryker’s ongoing efforts to expand its market presence and maintain financial stability.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.